Login / Signup

Use of high-dose steroid therapy: addition of anakinra in the treatment of severe COVID-19.

Kadir Gorkem GucluCeyda Geyiktepe-GüçlüOsman Faruk BayramlarGülşah TunçerMehtap Aydın
Published in: Revista da Associacao Medica Brasileira (1992) (2024)
The addition of anakinra to steroid treatment resulted in a significant decrease in biochemical parameters. However, no significant difference was observed in the oxygen status between the groups. The addition of anakinra to steroid treatment did not decrease mortality. Clinicians should be aware of the complications of anti-inflammatory therapies.
Keyphrases
  • high dose
  • coronavirus disease
  • sars cov
  • low dose
  • risk factors
  • stem cells
  • cardiovascular disease
  • type diabetes
  • cardiovascular events
  • combination therapy
  • coronary artery disease
  • early onset
  • replacement therapy